Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
Price:
14.35
USD
3.24%
Market Closed
Market Cap:
$1.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
|
US |
|
N
|
NB Bancorp Inc
NASDAQ:NBBK
|
US |
|
F
|
Famous Brands Ltd
JSE:FBR
|
ZA |
|
LendLease Group
ASX:LLC
|
AU |
|
T
|
Totm Technologies Ltd
SGX:42F
|
SG |
|
BHP Group Ltd
ASX:BHP
|
AU |
|
Z
|
Zealand Pharma A/S
OTC:ZLDPF
|
DK |
|
P
|
Photon Capital Advisors Ltd
BSE:509084
|
IN |
|
M
|
Medibank Private Ltd
F:MPV
|
AU |
|
S
|
SUMBER ENERGI ANDALAN Tbk PT
IDX:ITMA
|
ID |
|
Marusan Securities Co Ltd
TSE:8613
|
JP |
|
Cardinal Energy Ltd (Alberta)
TSX:CJ
|
CA |
|
S
|
STMicroelectronics NV
XHAM:SGM
|
CH |
|
Shandong Xinneng Taishan Power Generation Co Ltd
SZSE:000720
|
CN |
|
Hyundai Livart Furniture Co Ltd
KRX:079430
|
KR |
|
MR Bricolage SA
PAR:ALMRB
|
FR |
|
Varta AG
OTC:VARGF
|
DE |
|
Ajmera Realty & Infra India Ltd
NSE:AJMERA
|
IN |
|
C
|
Capital Industrial Financial Services Group Ltd
HKEX:730
|
HK |
|
Global Partners LP
NYSE:GLP
|
US |
|
T
|
Taylor Maritime Investments Ltd
LSE:TMI
|
GG |
|
Deliveroo PLC
LSE:ROO
|
UK |
|
Miyakoshi Holdings Inc
TSE:6620
|
JP |
|
O
|
Osisko Development Corp
NYSE:ODV
|
CA |
Multiples-Based Value
The
Multiples-Based Value for
Amylyx Pharmaceuticals Inc (AMLX)
under the Base Case is
hidden
USD.
Compared with the current market price of 14.35 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AMLX Multiples-Based Value
LOCKED
Multiples Across Competitors
AMLX Competitors Multiples
Amylyx Pharmaceuticals Inc Competitors
Amylyx Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Amylyx Pharmaceuticals Inc
NASDAQ:AMLX
|
1.6B USD | 0 | -10.9 | -8.3 | -8.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
901.8B USD | 13.8 | 43.7 | 29.5 | 31.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
587.8B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
233B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299B USD | 4.6 | 16.4 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
235.8B CHF | 5.4 | 21.7 | 13.4 | 17.2 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
162.3B USD | 2.6 | 20.9 | 7.9 | 10.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.3B USD | 2.6 | 17.6 | 7.4 | 9.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
